CIHR investment at the University of Sherbrooke
From: Canadian Institutes of Health Research
Backgrounder
On November 5, 2018, Minister Bibeau highlighted an investment of $11.5 million in 16 health research projects at the University of Sherbrooke. In addition to this investment, five one-year bridge grants of $100,000 each were awarded. These bridge grants provide researchers with smaller funding amounts to support their research until the next competition.
The projects are supported through the two most recent Project Grant competitions, the Canadian Institutes of Health Research's (CIHR) largest funding program. Twice-yearly, this program awards multi-year grants to help researchers in different stages of their careers to carry out research projects that cover the full range of health research topics. Project grant recipients are leaders in their fields and their projects tackle pressing health issues that matter to Canadians.
CIHR has invested $277 million to support 369 research grants across Canada as part of the spring 2018 competition and $372 million to support 512 research projects for the fall 2017 competition. This investment in health research supports our economy and creates high quality middle class jobs. Each $100 million invested in health research represents 1,800 jobs for researchers and trainees.
Spring 2018 Project Grant Competition – University of Sherbrooke
| Grant recipient and institution | Project titleFootnote 1
| CIHR contribution |
|---|
| Guylain Boissonneault, University of Sherbrooke | Genetic instability of the haploid male germ cells | $669,376 over 5 years |
| Francois-Michel Boisvert, University of Sherbrooke | Ubiquitin-KEKS: Function of a Novel Ubiquitin Isoform Coded by UBBP4, a Gene Initially Annotated as a Pseudogene | $891,226 over 5 years |
| Mylaine Breton; Arnaud Duhoux; Geneviève Landry;
Lara Maillet, University of Sherbrooke |
Évaluation de l'implantation de l'accès adapté et de ses effets dans les groupes de médecine familiale universitaires | $520,200 over 4 years |
| André C. Carpentier, University of Sherbrooke | Quantifying Brown Adipose Tissue Thermogenesis in Obesity and Type 2 Diabetes | $1,055,700 over 5 years |
| Cynthia Gagnon; Bernard Brais; Luc J. Hébert, University of Sherbrooke | A comprehensive study of the natural history of ARSACS: An essential step towards clinical trial readiness and evidence-based interventions | $569,925 over 4 years |
| Pedro M. Geraldes, University of Sherbrooke | Phosphatases and mechanisms of poor collateral vessel formation in diabetes | $753,526 over 5 years |
| Nicolas Gévry, University of Sherbrooke | Deciphering the role of the nuclear receptor LRH-1 in the establishment of a specific transcriptional program in triple negative breast cancer | $868,276 over 5 years |
| Pierre Lavigne, University of Sherbrooke | Development of cancer therapies targeting Myc with cell penetrating b-HLH-LZ domains | $868,276 over 5 years |
| Olivier J. Lesur; Eric Marsault, University of Sherbrooke | Exploiting ELABELA and analogues to Protect from Septic Shock | $707,626 over 5 years |
| Nathalie Rivard, University of Sherbrooke | A critical role of Dual Specificity Phosphatase-4 in intestinal oncogenesis ? | $100,000 one-year bridge grant |
| Mélanie Lapalme; Yann Le Corff; Caroline E. Temcheff, University of Sherbrooke | Étude longitudinale prospective du développement des troubles de la personnalité au début de l'âge adulte chez des garçons et des filles qui présentaient des troubles de comportement perturbateur dès l'enfance : le rôle des facteurs de risque spécifiques en fonction du sexe et du genre | $100,000 one-year bridge grant |
| Sébastien Rodrigue, University of Sherbrooke | Engineering of a probiotic bacterium for precise microbiome editing | $100,000 one-year bridge grant |
| | | 9 projects for a total of $6,904,131
+ 3 $100,000 one-year bridge grants |
Fall 2017 Project Grant Competition – University of Sherbrooke
| Grant recipient and institution | Project titleFootnote 1
| CIHR contribution |
|---|
| Jean-Patrice Baillargeon, University of Sherbrooke | The Fit-for-Fertility Multicenter Randomized-Controlled Trial: Improving Reproductive, Maternal and Neonatal Outcomes in Women with Obesity and Infertility | $761,176 over 4 years |
| Luigi Bouchard, University of Sherbrooke | MicroRNAs in pregnancy and gestational diabetes: origin and functions for clinical applications | $455,175 over 3 years |
| François Boudreau, University of Sherbrooke | The Nuclear Receptor HNF4A as a Regulator of WNT Ligands: Biological Impact of this Novel Interaction in Gut Diseases | $1,082,475 over 5 years |
| Alain Frigon, University of Sherbrooke | Reactivating spinal locomotor circuits by non-task-specific sensory feedback from the limbs after complete spinal cord injury | $669,375 over 5 years |
| Eric Masse, University of Sherbrooke | Physiology and biochemistry of small regulatory RNAs | $738,225 over 5 years |
| Véronique Provencher; Vincent Defoy; William B. Mortenson; Fréderick Roy; Nathalie Veillette, University of Sherbrooke | Comparative effectiveness of a comprehensive, patient-centered hospital discharge planning intervention for frail older adults: feasibility study for a large mixed-method randomized pragmatic trial | $164,476 over 2 years |
| Alain Vanasse, University of Sherbrooke | Trajectoires de soins et conditions propices aux soins ambulatoires | $761,176 over 4 years |
| Guylain Boissonneault, University of Sherbrooke
| Genetic instability of the haploid male germ cells | $100,000 one-year bridge grant |
| Olivier J. Lesur; Eric Marsault, University of Sherbrooke | Exploiting ELABELA and Analogues to Protect from Septic Shock | $100,000 one-year bridge grant |
| | | 7 projects for a total of $4,632,078
+ 2 $100,000 one-year bridge grants |
Footnotes
- Footnote 1
-
Research project titles are provided in the language in which they were submitted in the application for funding.
Return to footnote 1 referrer
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full
here.
